TrustCore Financial Services’s AstraZeneca AZN Stock Holding History

TrustCore Financial Services’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$165K	Hold	1,216	–	–	0.01%	294
2022 Q3	$133K	Sell	1,216 -68	-5%	-$8.63K	0.01%	308
2022 Q2	$170K	Buy	1,284 +68	+6%	+$8.92K	0.02%	274
2022 Q1	$161K	Buy	+1,216	New	+$146K	0.01%	301
2021 Q1	–	Sell	-204	Closed	-$20K	–	918
2020 Q4	$20K	Buy	204 +180	+750%	+$19.1K	﹤0.01%	561
2020 Q3	$3K	Buy	+24	New	+$2.67K	﹤0.01%	724

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TrustCore Financial Services's AZN Position: Q4 2022 in Review

TrustCore Financial Services held its AstraZeneca (AZN) position steady in Q4 2022 at 1,216 shares worth $165K. The position accounts for 0.01% of the portfolio, ranked #294.

TrustCore Financial Services first reported a position in AZN in Q3 2020 and has held it in 6 quarters since. The position peaked at $170K in Q2 2022. 1,061 funds tracked by Wall St. Rank hold AZN as of Q4 2022.

TrustCore Financial Services held 1,216 shares of AstraZeneca worth $165K as of Q4 2022.
TrustCore Financial Services left its AstraZeneca share count unchanged in Q4 2022.
AstraZeneca made up 0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #294 holding.
TrustCore Financial Services first reported a position in AstraZeneca in Q3 2020 and has held it in 6 quarters since.
TrustCore Financial Services's AstraZeneca position peaked at $170K in Q2 2022.
1,061 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.